Novo Nordisk A/S

News

Novo Nordisk Insulin Analogs Have Proven Safety Profiles

On Friday June 26, Diabetologia, the journal of the European Association for the Study of Diabetes (EASD) published online data from four studies relating to a possible link between a long-acting insulin analog, insulin glargine, and cancer(1).